Reuters Health Report

Click to View in Browser 02/12/2014 Israel bars Gaza patients over 'Palestine' letterhead GAZA (Reuters) - Israel has denied entry permits to some 50 Palestinian medical patients from the Gaza Strip because the words "State of Palestine" appears on the letterhead of their application, officials said on Wednesday. China detains man for spreading 'panic' with bird flu rumors BEIJING (Reuters) - Police in central China have detained a man who spread "panic" with a graphic rumor about the arrival of bird flu in his home province, state media reported on Wednesday. Ventrus' anal fissure drug fails in trial, shares slump (Reuters) - Ventrus Biosciences Inc said its lead experimental drug to treat anal fissures failed to reduce pain more than a placebo in a late-stage trial, sending its shares plunging 67 percent in premarket trading. Britain to ban smoking in cars carrying children LONDON (Reuters) - Smoking will soon be banned in cars carrying children in Britain, the government said on Tuesday, under new laws aimed at reducing the effects of passive smoking on young people. Hempseed oil has healthy potential: study NEW YORK (Reuters Health) - With an ideal ratio of omega-6 and -3 fatty acids and some plant chemicals thought to lower high blood pressure, hempseed oil has potential as part of a heart-healthy diet, according to Spanish researchers. Kids may suffer in gap between haves and have-nots NEW YORK (Reuters Health) - In U.S. counties where personal incomes cluster on opposite sides of the rich and poor spectrum, children might endure more neglect and abuse, according to a new U.S. study. Weather may truly affect arthritis pain NEW YORK (Reuters Health) - For people with osteoarthritis of the hip, pain levels tracked with the weather over the course of a small two-year study, Dutch researchers say. Gilead COO: Analysts' sky-high hep C drug view 'not unreasonable' NEW YORK (Reuters) - When Gilead Sciences Inc declined to project 2014 revenue for its high-profile new hepatitis C drug last week, its shares fell nearly 7 percent over the next two days. FDA panel says data does not support lower heart risk of naproxen (Reuters) - An advisory panel to the U.S. Food and Drug Administration said on Tuesday that available evidence does not prove that the painkiller naproxen, sold under the brand names Aleve and Naprosyn, carries a lower cardiac risk than rival products. UK cost agency urges far wider use of statin drugs LONDON (Reuters) - Doctors should use cholesterol-lowering statin drugs much more widely to prevent heart attacks and strokes, according to Britain's healthcare cost-effectiveness watchdog. Related Video Bushfires flare up in South Australia Dutch engineers help with UK floods The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend